These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2785417)

  • 1. Factors influencing the acceleration of human factor XIa inactivation by antithrombin III.
    Scott CF; Colman RW
    Blood; 1989 May; 73(7):1873-9. PubMed ID: 2785417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heparin on the inactivation rate of human factor XIa by antithrombin-III.
    Scott CF; Schapira M; Colman RW
    Blood; 1982 Oct; 60(4):940-7. PubMed ID: 7115961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heparin-catalysed inhibition of human factor XIa by antithrombin III is dependent on the heparin type.
    Soons H; Tans G; Hemker HC
    Biochem J; 1988 Dec; 256(3):815-20. PubMed ID: 3265623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of factor XIa by antithrombin III.
    Soons H; Janssen-Claessen T; Tans G; Hemker HC
    Biochemistry; 1987 Jul; 26(15):4624-9. PubMed ID: 3499176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen.
    Scott CF; Schapira M; James HL; Cohen AB; Colman RW
    J Clin Invest; 1982 Apr; 69(4):844-52. PubMed ID: 7076850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heparin on the inhibition of the contact system enzymes.
    Colman RW; Scott CF; Pixley RA; de la Cadena RA
    Ann N Y Acad Sci; 1989; 556():95-103. PubMed ID: 2786690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.
    Holmer E; Kurachi K; Söderström G
    Biochem J; 1981 Feb; 193(2):395-400. PubMed ID: 6914196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel procoagulant and anticoagulant pathways for high molecular weight kininogen coagulant function.
    Olson ST; Sheffer R; Shore JD
    Agents Actions Suppl; 1992; 38 ( Pt 1)():241-8. PubMed ID: 1466276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of factor XIa and antithrombin in the presence and absence of heparin.
    Beeler DL; Marcum JA; Schiffman S; Rosenberg RD
    Blood; 1986 May; 67(5):1488-92. PubMed ID: 3486013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-stimulated inhibition of factor IXa generation and factor IXa neutralization in plasma.
    Pieters J; Lindhout T; Willems G
    Blood; 1990 Aug; 76(3):549-54. PubMed ID: 2165828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a heparin binding site on the heavy chain of factor XI.
    Zhao M; Abdel-Razek T; Sun MF; Gailani D
    J Biol Chem; 1998 Nov; 273(47):31153-9. PubMed ID: 9813019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
    von dem Borne PA; Meijers JC; Bouma BN
    Thromb Haemost; 1996 Sep; 76(3):347-53. PubMed ID: 8883269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III.
    Pixley RA; Schapira M; Colman RW
    Blood; 1985 Jul; 66(1):198-203. PubMed ID: 3873967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
    Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
    Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis of the heparin-enhanced plasmin--antithrombin III reaction. Apparent catalytic role of heparin.
    Machovich R; Bauer PI; Arányi P; Kecskés E; Büki KG; Horváth I
    Biochem J; 1981 Dec; 199(3):521-6. PubMed ID: 6462134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.
    Cerskus AL; Birchall KJ; Ofosu FA; Hirsh J; Blajchman MA
    Can J Biochem Cell Biol; 1984 Oct; 62(10):975-83. PubMed ID: 6509363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Characterization of assembly, product formation, and heparin dissociation steps in the factor Xa reaction.
    Craig PA; Olson ST; Shore JD
    J Biol Chem; 1989 Apr; 264(10):5452-61. PubMed ID: 2925612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
    Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
    J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the kinetic behavior of human and bovine proteins in the heparin-catalyzed antithrombin III/thrombin reaction.
    Cunningham MT; Nelsestuen GL
    Biochim Biophys Acta; 1987 Jan; 911(1):66-70. PubMed ID: 3790599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.